About

Furkan Dursun is a urological surgeon and researcher whose work sits at the intersection of minimally invasive surgery, robotic-assisted techniques, and urologic oncology. His research spans several critical domains, including testicular cancer management, bladder cancer, renal cell carcinoma, and urogynecological conditions such as stress urinary incontinence and pelvic organ prolapse. Dursun has made particularly notable contributions to the growing evidence base for robot-assisted retroperitoneal lymph node dissection (R-RPLND), with his 2023 systematic review garnering 31 citations and establishing important benchmarks for the safety and feasibility of this minimally invasive approach compared to open surgery. His 2022 analysis of survival outcomes following minimally invasive versus open radical nephrectomy (20 citations) further underscores his commitment to optimizing oncological care through less invasive surgical pathways. Dursun has also advanced the field of robotic-assisted urogynecology, publishing influential case series on robotic Burch urethropexy and sacrocolpopexy. Collectively, his publications — accumulating over 90 citations across a focused body of work — reflect a researcher dedicated to rigorously evaluating emerging surgical technologies and improving patient outcomes across diverse urological and pelvic floor conditions.

Research Focus

Key Achievements

5
H-Index
9
Papers
91
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes
31 citations · 2023
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: The University of Texas at San Antonio Health Science Center, The University of Texas Medical Branch at Galveston, The University of Texas Health Science Center at Houston

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago